Literature DB >> 2157682

Anti-migraine drugs in development: advances in serotonin receptor pharmacology.

P P Humphrey1, W Feniuk, M J Perren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157682     DOI: 10.1111/j.1526-4610.1990.hed30s1012.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

Review 2.  Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.

Authors:  Jonathan Jia Yuan Ong; Milena De Felice
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 3.  5-Hydroxytryptamine and the pathophysiology of migraine.

Authors:  P P Humphrey
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 4.  What is migraine? Controversy and stalemate in migraine pathophysiology.

Authors:  J Edmeads
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 5.  Preclinical neuropharmacology of naratriptan.

Authors:  Geoffrey A Lambert
Journal:  CNS Drug Rev       Date:  2005

6.  Sumatriptan absorption from different regions of the human gastrointestinal tract.

Authors:  P E Warner; K L Brouwer; E K Hussey; G E Dukes; W D Heizer; K H Donn; I M Davis; J R Powell
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

Review 7.  Neurovascular contributions to migraine: Moving beyond vasodilation.

Authors:  Blaine Jacobs; Gregory Dussor
Journal:  Neuroscience       Date:  2016-06-14       Impact factor: 3.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.